Researchers assessed clinical incidence of pruritus in patients with myeloproliferative neoplasms.
Researchers sought to determine whether treatment with hydroxyurea for patients with MPNs would lead to a higher risk of secondary malignancies.
A review of myelofibrosis, including an update on treatment options, was presented at the 2023 ONA Summit.
Researchers sought to determine if momelotinib provided better improvements in anemia in patients with myelofibrosis, compared with treatment with danazol.
Researchers sought to verify the association of mutations in the splicing pathway gene SF3B1 with low bone marrow blast counts and increased ring sideroblasts in MDS.